SPRAVATO®, the only FDA-approved nasal spray for
adult patients with two forms of challenging-to-treat
major depressive disorder (MDD):

• Adults with MDD who’ve had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD)

• Depressive symptoms in adults with MDD with suicidal thoughts or actions (MDSI)

Esketamine is an intranasal form of ketamine that has been shown to have rapid, powerful antidepressant effects. After an initial consultation, we create your individualized ketamine treatment plan. Your treatment plan can include many different modalities, including (but not limited to) breathwork, visualization, music, intention setting, and talk therapy.

Click the image below to be taken to the Spravato website for more information.